云南高校图书馆联盟文献共享服务平台- PHARMACY

PHARMACY: 作品数：200被引量：142H指数：5; 导出分析报告; 相关领域：医药卫生更多>>; 相关作者：陈敏魏明月于广军王淑卢金淼更多>>; 相关机构：复旦大学上海市儿童医院中山大学附属第六医院中山大学孙逸仙纪念医院更多>>; 相关期刊：更多>>; 相关基金：国家自然科学基金World Health Organization江苏省高等学校大学生实践创新训练计划项目河北省自然科学基金更多>>

Information for Authors: 《Asian Journal of Social Pharmacy》2025年第1期94-96,共3页; Aims and Scope Asian Journal of Social Pharmacy(AJSP)is peer-reviewed quarterly English journal jointly hosted by Herbal Font Pharmaceutical Limited and Shenyang Pharmaceutical University.AJSP is dedicated to providin...; 关键词：jointly JOURNAL PHARMACY

Information for Authors: 《Asian Journal of Social Pharmacy》2024年第4期409-411,共3页; Aims and Scope Asian Journal of Social Pharmacy(AJSP)is peer-reviewed quarterly English journal jointly hosted by Herbal Font Pharmaceutical Limited and Shenyang Pharmaceutical University.AJSP is dedicated to providin...; 关键词：JOURNAL jointly PHARMACY

Announcing 2023 Impact Factor for Acta Pharmaceutica Sinica B: 《Acta Pharmaceutica Sinica B》2024年第12期I0002-I0002,共1页; Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the 2023 Journal Impact Factor(JIF)of APSB is now 14.8(13.9 without self-citations)according to the latest Clarivate Journal Citation Reports released on ...; 关键词：PHARMACY IMPACT RANKS

News: 《Acta Pharmaceutica Sinica B》2024年第11期I0002-I0002,共1页; Announcing 2023 Impact Factor for Acta Pharmaceutica Sinica B Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the 2023 Journal Impact Factor(JIF)of APSB is now 14.8(13.9 without self-citations)according...; 关键词：PHARMACY IMPACT RANKS

Information for Authors: 《Asian Journal of Social Pharmacy》2024年第3期307-309,共3页; Aims and Scope Asian Journal of Social Pharmacy(AJSP)is peer-reviewed quarterly English journal jointly hosted by Herbal Font Pharmaceutical Limited and Shenyang Pharmaceutical University.AJSP is dedicated to providin...; 关键词：JOURNAL jointly PHARMACY

Correction: 《Integrative Medicine Discovery》2024年第9期1-2,共2页; Editorial Office of Integrative Medicine Discovery 2024,Vol.8:e24008 DOI:10.53388/IMD202408008 Title:Exploring the molecular mechanism of action of curcumin for the treatment of diabetic retinopathy,using network phar...; 关键词：COLLEGE PHARMACY HUBEI

Announcing 2022 Impact Factor for Acta Pharmaceutica Sinica B: 《Acta Pharmaceutica Sinica B》2023年第12期I0002-I0002,共1页; Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the 2022 Impact Factor(IF)of the journal is now 14.5(13.8 without self-citations)according to the latest Clarivate Journal Citation Reports released on Ju...; 关键词：JOURNAL PHARMACY IMPACT

Announcing 2022 Impact Factor for Acta Pharmaceutica Sinica B: 《Acta Pharmaceutica Sinica B》2023年第10期I0002-I0002,共1页; Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the 2022 Impact Factor(IF)of the journal is now 14.5(13.8 without self-citations)according to the latest Clarivate Journal Citation Reports released on Ju...; 关键词：JOURNAL PHARMACY IMPACT

Information for Authors: 《Asian Journal of Social Pharmacy》2023年第3期299-301,共3页; Aims and Scope.Asian Journal of Social Pharmacy(AJSP)is peer-reviewed quarterly English journal jointly hosted by Herbal Font Pharmaceutical Limited and Shenyang Pharmaceutical University.AJSP is dedicated to providin...; 关键词：jointly JOURNAL PHARMACY

Erratum to:Membrane fusion reverse micelle platforms as potential oral nanocarriers for efficient internalization of free hydrophilic peptides: 《Nano Research》2023年第7期10712-10712,共1页Mengting Lin Linjie Wu Yiying Lu Xiaoyan Bao Haiqing Zhong Qi Dai Qiyao Yang Yiyi Xia Xin Tan Yaxin Qin Ruolin Jiang Min Han; Erratum to Nano Research 2023,16(7):9768-9780 https://doi.org/10.1007/s12274-023-5645-7 The complete affiliations of co-author Yiying Lu is Institute of Pharmaceutics,College of Pharmaceutical Sciences,Zhejiang Univer...; 关键词：China PHARMACY POTENTIAL

PHARMACY